# Coloplast agrees to acquire Kerecis for up to $1.3B

Coloplast signed an agreement to acquire Kerecis, a biologics wound care company, for up to USD 1.3 billion, with an upfront cash payment of USD 1.2 billion. Kerecis is based in Ísafjörður, Iceland, and uses fish skin technology for wound healing.

- Type: Acquisition
- Announced: 2023-07-07
- Where: Ísafjörður, Iceland
- Value: $1.30B
- Status: announced
- Products: fish skin-based wound care biologics
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Coloplast](https://endata.com/companies/15184.md) (acquirer)
- [Kerecis](https://endata.com/companies/71300.md) (target)

## Sources

- [kerecis.com](https://www.kerecis.com/coloplast-announces-agreement-to-acquire-kerecis-and-raises-long-term-growth-expectations/), 2023-07-07: "We're excited to join the Coloplast family and have their support in becoming the world leader in tissue regeneration."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.